Ayurveda intervention as clinical trial against COVID-19
Phase 3
- Conditions
- Health Condition 1: U071- COVID 19 virus identified
- Registration Number
- CTRI/2022/02/040562
- Lead Sponsor
- All India Institute Of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Newly diagnosed COVID-19 confirmed by RT-PCR.
2.Mild to Moderate COVID-19 infection.
3.Comorbid conditions (HTN, Diabetes, Metabolic
Syndrome)
4.Willingness and ability to comply with trial and follow-up
procedures.
5.Ability to understand the nature of this trial and give written informed consent.
Exclusion Criteria
1.Patients with severe and critical infection will be excluded.
2.Patients with severe COVID-19 infection
3.Patients with respiratory failure who need mechanical ventilation
4.Patients who cannot take drug orally
5.Inability or unwillingness to comply with study and/or follow-up procedures
6.Enrolled in other researches for treatment of COVID-19 infection
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of the patients becoming RT â?? PCR Negative after being positive for covid-19Timepoint: baseline (day 0) and after 7th day (day 8) and after 10 days (day 11)
- Secondary Outcome Measures
Name Time Method Improvement in quality of life (SF-36 proforma will be used)Timepoint: 30 days follow up after stopping ayurvedic medication